Wells Fargo’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.8K | Buy |
+20,727
| New | +$62.8K | ﹤0.01% | 5012 |
|
|
2024
Q3 | – | Sell |
-500
| Closed | -$1.04K | – | 6573 |
|
|
2024
Q2 | $1.04K | Sell |
500
-70
| -12% | -$146 | ﹤0.01% | 5703 |
|
|
2024
Q1 | $2.29K | Buy |
570
+1
| +0.2% | +$4 | ﹤0.01% | 5615 |
|
|
2023
Q4 | $1.07K | Buy |
569
+4
| +0.7% | +$8 | ﹤0.01% | 5764 |
|
|
2023
Q3 | $944 | Buy |
565
+2
| +0.4% | +$3 | ﹤0.01% | 5841 |
|
|
2023
Q2 | $1.35K | Buy |
563
+3
| +0.5% | +$7 | ﹤0.01% | 5959 |
|
|
2023
Q1 | $1.75K | Buy |
560
+1
| +0.2% | +$3 | ﹤0.01% | 5931 |
|
|
2022
Q4 | $1.5K | Buy |
559
+1
| +0.2% | +$3 | ﹤0.01% | 5752 |
|
|
2022
Q3 | $1K | Sell |
558
-8
| -1% | -$14 | ﹤0.01% | 6136 |
|
|
2022
Q2 | $1K | Buy |
566
+6
| +1% | +$11 | ﹤0.01% | 6308 |
|
|
2022
Q1 | $3K | Hold |
560
| – | – | ﹤0.01% | 6246 |
|
|
2021
Q4 | $3K | Hold |
560
| – | – | ﹤0.01% | 6266 |
|
|
2021
Q3 | $3K | Buy |
560
+1
| +0.2% | +$5 | ﹤0.01% | 6174 |
|
|
2021
Q2 | $6K | Sell |
559
-67,733
| -99% | -$727K | ﹤0.01% | 5960 |
|
|
2021
Q1 | $1.08M | Buy |
68,292
+55,182
| +421% | +$869K | ﹤0.01% | 3939 |
|
|
2020
Q4 | $317K | Sell |
13,110
-3,453
| -21% | -$83.5K | ﹤0.01% | 4738 |
|
|
2020
Q3 | $279K | Buy |
16,563
+7,800
| +89% | +$131K | ﹤0.01% | 4622 |
|
|
2020
Q2 | $257K | Buy |
8,763
+8,657
| +8,167% | +$254K | ﹤0.01% | 4612 |
|
|
2020
Q1 | $2K | Buy |
+106
| New | +$2K | ﹤0.01% | 5681 |
|
|
2016
Q2 | – | Sell |
-31
| Closed | -$10K | – | 5945 |
|
|
2016
Q1 | $10K | Buy |
31
+12
| +63% | +$3.87K | ﹤0.01% | 5451 |
|
|
2015
Q4 | $12K | Buy |
19
+18
| +1,800% | +$11.4K | ﹤0.01% | 5432 |
|
|
2015
Q3 | $1K | Sell |
1
-9
| -90% | -$9K | ﹤0.01% | 5772 |
|
|
2015
Q2 | $7K | Buy |
+10
| New | +$7K | ﹤0.01% | 5663 |
|